Global Neonatal Intensive Care Respiratory Devices Market Size Likely to Grow at a CAGR of 10.5% By 2035

The market size of the global neonatal intensive care respiratory devices will be estimated at USD 2.1 billion in 2025 and is expected to grow between USD 2.3 billion in 2026 and about USD 5.7 billion by 2035 with a current CAGR of 10.5% during the period of 2026 to 2035.

Neonatal Intensive Care Respiratory Devices Market Revenue and Trends

The medical devices used in neonatal intensive care respiratory systems exist to provide breathing assistance to newborns who need breathing support due to their immature lung development and existing respiratory disorders. The Neonatal Intensive Care Units (NICUs) make use of these devices to deliver oxygen while they maintain airway pressure and provide ventilation support and control through their ability to administer respiratory medications in a secure environment. The typical equipment used in this field consists of neonatal ventilators and continuous positive airway pressure (CPAP) systems and high-flow nasal cannulae (HFNC) and nebulizers and oxygen delivery systems. The vulnerable newborns who need advanced respiratory care should receive their primary goal of treatment which aims to enhance oxygen levels while decreasing breathing difficulties and preventing lung damage and increasing their chances of surviving.

What are the Factors That Have a Significant Contribution to the Growth of the Neonatal Intensive Care Respiratory Devices Market?

The neonatal intensive care respiratory devices market experiences growth because hospitals develop new neonatal intensive care units which they use to treat high-risk and premature infants. Hospitals are expanding their use of respiratory support technologies because they invest in new NICU beds and advanced neonatal care facilities and modern equipment. The market experiences expansion in emerging economies because these countries focus on providing essential neonatal care services while decreasing infant death rates which drives demand for neonatal respiratory devices.

Additionally, the market expansion results from increasing people knowledge about neonatal respiratory disorders which lets medical professionals and parents recognize these disorders earlier. The combination of improved screening methods and enhanced delivery room and NICU monitoring systems and standardized neonatal care protocols enables medical staff to detect respiratory disorders at their initial stages which creates urgent requirements for respiratory assistance. The use of CPAP and ventilators and oxygen therapy systems become more effective when medical staff can diagnose patients earlier because this leads to improved clinical results and increased use of neonatal intensive care respiratory devices.

Segment Insight

By Device Type

The ventilators segment growing at a significant rate over the projected period. Their primary purpose of their work exists to provide treatment for breathing disorders which lead to respiratory failure in premature newborns who are in critical condition. Neonatal ventilators function as essential equipment for advanced NICUs because they deliver controlled mechanical breathing support to infants who cannot breathe independently. The combination of rising preterm birth rates together with lung immaturity in affected infants has created an increasing need for both invasive and non-invasive ventilatory support methods.

Regional Insights

North America held the highest market share in 2025. The region experiences increased adoption of devices because of government and private financial support for neonatal care together with widespread public knowledge about neonatal respiratory disorders.

Besides, the Asia Pacific market has the highest rate of growth in the neonatal intensive care respiratory devices market. The regional market shows both increased product adoption and revenue growth because clinicians and caregivers now better understand neonatal care best practices which leads to higher usage of advanced neonatal respiratory technologies.

Report Scope

Recent Developments

• In January 2026, mOm Incubators has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its mOm Essential incubator, which functions as the first portable incubator that delivers thermoregulation for premature infants. The mOm Essential Incubator’s design lets it be used in a variety of settings and lets mother and baby stay together. The company will work with healthcare providers to deploy the incubators across various labor and delivery environments throughout the United States, which will result in faster access to neonatal medical treatment. (Source: https://www.mpo-mag.com/breaking-news/fda-oks-mom-essential-incubator-for-premature-babies/)

Top Players in the Neonatal Intensive Care Respiratory Devices Market and Their Offerings

• Inspiration Healthcare Group PLC

• GE Healthcare

• Cardinal Health Inc.

• Drägerwerk AG & Co. KGaA

• Fisher & Paykel Healthcare Limited

• BD

• Getinge AB

• Hamilton Medical AG

• Ambu A/S

• Masimo Corporation

• Medtronic plc

• Philips

• ResMed Inc.

• Smiths Group plc

• Vyaire Medical Inc.

• Others

The Neonatal Intensive Care Respiratory Devices Market is segmented as follows:

By Device Type

• Nebulizers

• Continuous Positive Airway Pressure (CPAP) Devices

• Ventilators

• Inhalers

• Apnea Monitors

• Others

By End User

• Hospitals

• Nursing Homes

• Specialty Clinics

• Others

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America